BNBX - AlphaYou

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes

Analysts

What do analysts expect?

No analyst estimates.

Questions about BNBX filings

Are insiders buying or selling Applied DNA Sciences, Inc. (BNBX) stock?

Neither. Applied DNA Sciences, Inc. (BNBX) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNBX recently?

None. No member of Congress disclosed a BNBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNBX smart-money data?

This summary uses filings available on Nov 9, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.

No recent filings found.

3 funds hold a position.

Questions about BNBX filings

Are insiders buying or selling Applied DNA Sciences, Inc. (BNBX) stock?

Neither. Applied DNA Sciences, Inc. (BNBX) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNBX recently?

None. No member of Congress disclosed a BNBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNBX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$605.3K

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	Not on file	No estimate	$605.3KSEC filing	+98.9%from $304.4K
Mar 31, 2026Reported May 15, 2026	-$0.68Reported	No estimate	$1.0MSEC filing	+34.3%from $762.8K
Dec 31, 2025Reported Feb 12, 2026	-$2.08Reported	No estimate	$565.4KSEC filing	-35.0%from $870.3K
Jun 30, 2025Reported Aug 14, 2025	$20.79est. -$37.50	+$58.29beat	$304.4KSEC filing	-35.6%from $472.8K
Mar 31, 2025Reported May 15, 2025	-$230.31est. -$45.00	-$185.31miss	$762.8KSEC filing	-17.9%from $929.6K
Dec 31, 2024Reported Feb 13, 2025	-$27.84est. -$0.31	-$27.53miss	$870.3KSEC filing	-2.3%from $891.2K
Sep 30, 2024Reported Dec 18, 2024	-$240.01Reported	No estimate	$2.1M · FYSEC filing	No year-ago quarter
Jun 30, 2024Reported Aug 8, 2024	$0.47est. -$3.70	+112.70%beat	$472.8KSEC filing	-83.8%from $2.9M

Earnings per share comes from Yahoo Finance where available, then Alpha Vantage or the company release. Revenue comes from company releases, SEC filings, Alpha Vantage or Yahoo Finance. A beat or miss needs an analyst estimate on the same basis as the reported figure, so quarters without one show none. Non-USD amounts carry their currency code.

52-wk high: $7.15
52-wk low: $0.35
Mkt cap: $3.3M
P/E: 0.0x
ROE: -306.8%
Fwd P/E: 158.7x
Beta: 0.47
P/S: 1.6x
P/B: 0.3x
Profit margin: +0.0%
Op margin: -636.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.00
Forward P/E: 158.73
Market cap: $3M

Valuation

P/S1.57
P/B0.26

Quality

Operating margin-636.0%
ROE-306.8%
ROA-152.1%

Growth

Beta0.47

Technicals

Price structure

Market data unavailable.

Smart money at a glance

Filings to Nov 9, 2026

No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.

Company insidersForm 4, 90 days: $0
CongressSTOCK Act, 180 days: None
Big funds13F, latest quarter: No large changes

Analysts

What do analysts expect?

No analyst estimates.

Questions about BNBX filings

Are insiders buying or selling Applied DNA Sciences, Inc. (BNBX) stock?

Neither. Applied DNA Sciences, Inc. (BNBX) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNBX recently?

None. No member of Congress disclosed a BNBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNBX smart-money data?

No recent filings found.

3 funds hold a position.

Questions about BNBX filings

Are insiders buying or selling Applied DNA Sciences, Inc. (BNBX) stock?

Neither. Applied DNA Sciences, Inc. (BNBX) insiders filed no open-market purchases or sales in the 90 days to Nov 9, 2026, according to SEC Form 4 filings.

Which members of Congress have traded BNBX recently?

None. No member of Congress disclosed a BNBX trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

How current is this BNBX smart-money data?

Checking federal contract awards

Unlock everything for $29/month

Unlock for $29/month

Reported Aug 13, 2026

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K Every filing

Last report

Aug 13, 2026

Period ending

Jun 30, 2026

Earnings per share

Unavailable

EPS comparison unavailable

Revenue

$605.3K

SEC filing

Next report

What the street expects next

Previous reports

Quarter / reported	Earnings per share	Beat or miss	Revenue / income	Revenue vs last year
Jun 30, 2026Reported Aug 13, 2026	Not on file	No estimate	$605.3KSEC filing	+98.9%from $304.4K
Mar 31, 2026Reported May 15, 2026	-$0.68Reported	No estimate	$1.0MSEC filing	+34.3%from $762.8K
Dec 31, 2025Reported Feb 12, 2026	-$2.08Reported	No estimate	$565.4KSEC filing	-35.0%from $870.3K
Jun 30, 2025Reported Aug 14, 2025	$20.79est. -$37.50	+$58.29beat	$304.4KSEC filing	-35.6%from $472.8K
Mar 31, 2025Reported May 15, 2025	-$230.31est. -$45.00	-$185.31miss	$762.8KSEC filing	-17.9%from $929.6K
Dec 31, 2024Reported Feb 13, 2025	-$27.84est. -$0.31	-$27.53miss	$870.3KSEC filing	-2.3%from $891.2K
Sep 30, 2024Reported Dec 18, 2024	-$240.01Reported	No estimate	$2.1M · FYSEC filing	No year-ago quarter
Jun 30, 2024Reported Aug 8, 2024	$0.47est. -$3.70	+112.70%beat	$472.8KSEC filing	-83.8%from $2.9M

52-wk high: $7.15
52-wk low: $0.35
Mkt cap: $3.3M
P/E: 0.0x
ROE: -306.8%
Fwd P/E: 158.7x
Beta: 0.47
P/S: 1.6x
P/B: 0.3x
Profit margin: +0.0%
Op margin: -636.0%

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 0.0%
P/E: 0.00
Forward P/E: 158.73
Market cap: $3M

Valuation

P/S1.57
P/B0.26

Quality

Operating margin-636.0%
ROE-306.8%
ROA-152.1%

Growth

Beta0.47

Technicals

Price structure

Market data unavailable.

Applied DNA Sciences, Inc.

Smart money at a glance

What do analysts expect?

Questions about BNBX filings

Questions about BNBX filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Applied DNA Sciences, Inc.

Smart money at a glance

What do analysts expect?

Questions about BNBX filings

Questions about BNBX filings

How top traders are positioned

Unlock everything for $29/month

Results versus expectations

What the street expects next

Previous reports

Is the business strong?

Price structure

Ask it in Claude or ChatGPT.

Applied DNA Sciences, Inc.

Overview

Questions about BNBX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.

Applied DNA Sciences, Inc.

Overview

Questions about BNBX filings

Smart money

Unlock everything for $29/month

Earnings

Previous reports

Financials

Technicals

Ask it in Claude or ChatGPT.